Ergebnis der Suchanfrage nach celle

Orte

Alle 16 Treffer anzeigenweniger anzeigen

Landkreis Celle LK Celle - Wienhausen Nienhagen (Landkreis Celle)Stadt Celle Altencelle Westercelle

Themen

Excellence Award HR Excellence Award HR Excellence Awards

Inhalte

Neueste Relevanteste

Filtern

630 Treffer

03.08.2009 – 07:04
Finanzen
Boehringer Ingelheim
Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 (Tovok(TM)) as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients With EGFR Mutations
Ingelheim, Germany (ots/PRNewswire) - - Data From Phase II Studies Investigating BIBW 2992 (Tovok(TM)) and BIBF 1120 (Vargatef(TM)) in NSCLC Patients Presented at 13th World Conference on Lung Cancer (WCLC) INGELHEIM, Germany, August 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International ...
mehr
20.07.2009 – 09:06
Wirtschaft
Boehringer Ingelheim
Head-to-Head Trial Demonstrates Viramune(R)'s Similar Efficacy and Superior Effect on Lipid Profile Compared to atazanavir/ritonavir
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
mehr
06.07.2009 – 12:10
Wirtschaft
Boehringer Ingelheim
European Commission Approves Statement on Lipid Improvement for VIRAMUNE(R) Label
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical Products ...
mehr
26.05.2009 – 13:20
Finanzen
ElringKlinger AG
EANS-News: High approval rates at ElringKlinger AGM - Dividend of EUR 0.15 per share agreed
Annual General Meeting Further inquiry note: Stephan Haas Investor Relations/PR Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade München / free ...
mehr
19.05.2009 – 14:51
Wirtschaft
ertex solar
ertex solar at Intersolar: Innovation builds on tradition
Amstetten/Munich (ots) - For ertex solar tradition is not appropriate with imagination, but rather with the traditional slogan of "no limits". This proves the Austrian solar expert once more at the newly designed booth at Intersolar 2009 in Munich. A photovoltaic façade whit the dimension of 5.7 meters in width and 3.0 meters in height, consisting of four elements (each 1.4 x 3.0 m) shows impressively the feasibility of ...
mehr
07.05.2009 – 08:00
Finanzen
ElringKlinger AG
EANS-Adhoc: ElringKlinger with positive net income in Q1 2009 despite slump in automobile markets
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, ...
mehr
30.03.2009 – 08:17
Finanzen
ElringKlinger AG
EANS-Adhoc: ElringKlinger AG / ElringKlinger gears up for weak automotive markets after fiscal 2008
Further inquiry note: Stephan Haas Phone: +49 (0) 7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
mehr
03.02.2009 – 10:03
Finanzen
init innovation in traffic systems AG
GE Transportation LLC names INIT as subcontractor for Golden Gate Bridge, Highway and Transportation District project
Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 6100-102 E-Mail: aweiss@initag.de Branche: Semiconductors & active components ISIN: DE0005759807 WKN: 575980 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / ...
mehr
10.12.2008 – 11:20
Panorama
BASF SE
BASF Podcast: The Chemical Reporter - How does a plasma monitor work?
Ludwigshafen (ots) - In simple terms, behind the glass on the front of a plasma screen you'll find a whole lot of tiny cells that are filled with one of the 'noble' gases, generally neon or xenon. Each of these cells represents a single point - a pixel. If a voltage is applied to the gas, then it ...
Ein Audio
mehr
17.11.2008 – 08:06
Wirtschaft
Boehringer Ingelheim
First Pivotal Trials Begin for Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef(TM) (BIBF 1120)
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has marked a new ...
mehr
29.10.2008 – 11:20
Panorama
BASF SE
BASF Podcast: The Chemical Reporter - What are liquid crystals?
Ludwigshafen (ots) - After the advent of liquid crystal displays, or LCDs, everybody nowadays has at least heard the term 'liquid crystal'. The high-tech screens are everywhere: in computer monitors, cell phones, digital cameras, and calculators. In entertaining episodes our Chemical Reporter ...
Ein Audio
mehr
23.10.2008 – 11:50
Finanzen
LPKF Laser & Electronics AG
LPKF Laser & Electronics AG´s solar business develops positively
LPKF interviewed by Dr. Kalliwoda Research Further inquiry note: Ulrike Thoms-von Meding LPKF Laser & Electronics AG Tel.: +49(0)5131 7095 326 u.thomsvonmeding@lpkf.de Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse ...
mehr
22.10.2008 – 12:21
Wirtschaft
Boehringer Ingelheim
Boehringer Ingelheim Broadens Oncology Pipeline With Promising New Data for Potentially First in Class Plk1 Inhibitor
Ingelheim, Germany (ots/PRNewswire) - - BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme - For non-US Healthcare Media Boehringer Ingelheim's most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, has shown ...
mehr
19.10.2008 – 13:17
Finanzen
ElringKlinger AG
euro adhoc: ElringKlinger AG / Earnings Forecast / ElringKlinger adjusts annual forecast for 2008 due to significant deterioration in economic conditions
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
mehr
17.10.2008 – 15:58
Finanzen
InCity Immobilien AG
InCity Immobilien AG expands its business focus to include retail property
- Expansion of REIS segment with additional retail properties - Capital commitment of 10 million euro from investors - Significant earnings lift expected from 2009 Further inquiry note: InCity Immobilien AG André Peto Phone: +49 (0) 221 95 27 57 55 a.peto@incity.ag Investor Relations Dariusch Manssuri Phone: +49 (0) 221 91 40 970 dariusch.manssuri@ir-on.com Branche: ...
mehr
17.10.2008 – 12:36
Wirtschaft
Boehringer Ingelheim
From Curiosity to Discovery: Boehringer Ingelheim's Pipeline Update Unveils Novel Investigational Compounds Heralding the Company's Entry Into Type 2 Diabetes
Ingelheim and Biberach, Germany (ots/PRNewswire) - - Boehringer Ingelheim Oncology Pipeline Advances: Two Leading Compounds are Entering Phase III Trials - Boehringer Ingelheim's Investigational Compound in Development for the Treatment of Pre-Menopausal Women Suffering From Hypoactive Sexual Desire Disorder (HSDD) ...
mehr
01.10.2008 – 11:20
Panorama
BASF SE
BASF Podcast: The Chemical Reporter - What are emulsifiers?
Ludwigshafen (ots) - If you put the oil and water together in a single glass, then they act like a couple of suspicious neighbors. Each quickly finds its own level - the oil on top and the water below - and has as little interaction with the other as possible. There's a kind of fence between them that each is unable to overcome on its own: this ...
Ein Audio
mehr
17.09.2008 – 11:20
Panorama
BASF SE
BASF Podcast: The Chemical Reporter - What is mother-of-pearl?
Ludwigshafen (ots) - While taking a walk along the beach, you might have noticed shells that have inner surfaces that shimmer in colorful patterns when they reflect the sunlight. The iridescent substance responsible for it is called nacre, or more commonly: mother-of-pearl. The name says it all, ...
Ein Audio
mehr
10.09.2008 – 11:20
Panorama
BASF SE
BASF Podcast: BASF Podcast: Organic Photovoltaics - Flexible and transparent solar cells
Ludwigshafen (ots) - In this podcast you will learn how organic photovoltaics helps to produce solar cells with completely new qualities. In organic photovoltaics dyes are used that are able to convert light into electrical energy. Due to the extremely thin photovoltaic layer, flexible or even ...
Ein Audio
mehr
27.08.2008 – 09:56
Finanzen
Basler AG
Basler AG: Exclusive Cooperation with Komax in the Solar Cell Module Inspection Field
Further inquiry note: Verena Fehling Assistant to the Board / Investor Relations Telefon: +49(0)4102 463-100 E-Mail: Verena.Fehling@baslerweb.com Branche: Semiconductors & active components ISIN: DE0005102008 WKN: 510200 Index: CDAX Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / ...
mehr
13.08.2008 – 11:20
Panorama
BASF SE
BASF Podcast: Ionic Liquids - Liquid Salts with many Talents
Ludwigshafen (ots) - In this podcast you will learn how the unique characteristics of liquid salts make ionic liquids so interesting for industry. Ionic liquids are molten salts that are also in a liquid form at room temperature. The unique characteristics of these liquid salts are the very thing that makes ionic liquids so interesting for ...
Ein Audio
mehr
08.08.2008 – 15:23
Finanzen
Basler AG
Exclusive Cooperation with Manz Automation AG in the Solar Cell Inspection Field
Further inquiry note: Verena Fehling Assistant to the Board / Investor Relations Telefon: +49(0)4102 463-100 E-Mail: Verena.Fehling@baslerweb.com Branche: Semiconductors & active components ISIN: DE0005102008 WKN: 510200 Index: CDAX Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / ...
mehr
30.05.2008 – 13:24
Finanzen
ElringKlinger AG
ElringKlinger AGM declares dividend increase and stock split - Strong financial year in 2007
Further inquiry note: Stephan Haas Investor Relations Manager Telefon: +49(0)7123 724-137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Düsseldorf / free trade Börse ...
mehr
08.05.2008 – 08:13
Finanzen
ElringKlinger AG
euro adhoc: ElringKlinger AG / Financial Figures/Balance Sheet / ElringKlinger increases sales and earnings in first quarter of 2008
Further inquiry note: Stephan Haas Investor Relations Manager Telefon: +49(0)7123 724-137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse ...
mehr
25.04.2008 – 16:33
Wirtschaft
Boehringer Ingelheim
Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120)
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 (planned tradename ...
mehr
31.03.2008 – 17:19
Wirtschaft
Boehringer Ingelheim
Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event
Ingelheim, Germany (ots/PRNewswire) - - Results of 25,620 Patient Study ONTARGET(R) (ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial) Presented Today at the 57th Annual Scientific Session of the American College of Cardiology(1) - For Non-US Healthcare Media The results of the ...
mehr
14.02.2008 – 13:00
Finanzen
ElringKlinger AG
euro adhoc: ElringKlinger AG / Mergers - Acquisitions - Takeovers / ElringKlinger close to signing deal for takeover of Swiss heat shield specialist SEVEX AG
Further inquiry note: ElringKlinger AG Kathrin Müller Tel. +49 (0) 7123/724-631 kathrin.mueller@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free ...
mehr
19.11.2007 – 20:06
Finanzen
LPKF Laser & Electronics AG
euro adhoc: LPKF Laser & Electronics AG / quarterly or semiannual financial statement / LPKF: Strong profitable growth anticipated for 2008 to 2010
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 19.11.2007 AD-HOC-ANNOUNCEMENT PURSUANT TO SECTION 15 WPHG LPKF Laser & Electronics AG: Strong profitable growth anticipated for 2008 to 2010 The Group generated the following ...
mehr
08.11.2007 – 08:17
Finanzen
ElringKlinger AG
euro adhoc: ElringKlinger AG / quarterly or semiannual financial statement / ElringKlinger records double-digit growth in sales revenues and earnings over first nine months of 2007
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 9-month report 08.11.2007 Dettingen/Erms (Germany), November 8, 2007 - - - The ElringKlinger Group succeeded in further expanding both its sales revenues and earnings in the first nine months ...
mehr
29.10.2007 – 10:00
Finanzen
Wacker Chemie AG
SCHOTT and WACKER lay the cornerstone for new solar wafer production plant in Jena
Joint Press Release Issued by WACKER and SCHOTT - WACKER SCHOTT SOLAR will produce multicrystalline silicon wafers for solar cells - Investment of approx. EUR50 million initially creates 140 new jobs at the Jena site - New production facility expected to reach a capacity of 100 megawatts already by the end of 2008 ots.CorporateNews transmitted by euro adhoc. The ...
mehr

Vorherige13141516171819202122Nächste